With plasma collection as its stock-in-trade, the struggles of CSL during the coronavirus lockdown were understandable. But a rebound—fueled by a surge in post-pandemic collections and an $11.7 ...
CSL’s head of investor relations, Chris Cooper, is understood to be leaving the Australian healthcare group as the $87bn blue ...
Better times ahead? The post Expert sees 34% upside potential for CSL shares despite ongoing challenges appeared first on The ...
CSL Ltd said on Tuesday the fees it pays people to donate blood plasma, the core ingredient of its treatments, were stabilising after COVID-19 movement restrictions forced the Australian biomedical ...
LAS VEGAS (KTNV) — A new plasma donation center is open in Las Vegas as part of an effort to meet a critical need for plasma in the valley. CSL Plasma is looking to address that need by continuing its ...
Setting new standards in responsible innovation, CSL's Broadmeadows facility blends Pharma 4.0™ principles with sustainable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback